Clinical Trial Update: NSAIDs and PGE2 Levels in Vitrectomy Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating NSAIDs and PGE2 levels in vitrectomy patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreous Inflammation

Drugs mentioned

• NSAIDs (nonsteroidal anti-inflammatory drugs) (nonsteroidal anti-inflammatory drugs)

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Vitreous Inflammation | Phase 3 | Status: COMPLETED